Symbol="RNA"
AssetType="Common Stock"
Name="Avidity BiosciencesÂ Inc"
Description="Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California."
CIK="1599901"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10975 N. TORREY PINES RD.,, #150, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="667117000"
EBITDA="-200584992"
PERatio="None"
PEGRatio="0"
BookValue="7.89"
DividendPerShare="0"
DividendYield="0"
EPS="-3.17"
RevenuePerShareTTM="0.167"
ProfitMargin="0"
OperatingMarginTTM="-20.91"
ReturnOnAssetsTTM="-0.244"
ReturnOnEquityTTM="-0.411"
RevenueTTM="9662000"
GrossProfitTTM="-141180000"
DilutedEPSTTM="-3.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.244"
AnalystTargetPrice="37"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="119.0"
PriceToBookRatio="1.576"
EVToRevenue="24.07"
EVToEBITDA="-1.227"
Beta="-0.0651"
num_52WeekHigh="25.74"
num_52WeekLow="8.86"
num_50DayMovingAverage="11.05"
num_200DayMovingAverage="15.91"
SharesOutstanding="70819000"
DividendDate="None"
ExDividendDate="None"
symbol="RNA"
open="9.48"
high="9.54"
low="9.28"
price="9.52"
volume="529248.00"
latest_trading_day="2023-08-01"
previous_close="9.51"
change="0.01"
change_percent="0.1052%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="85"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="1234974"
Change_recent_avg="-0.08"
Delta_recent_avg="0.75"
Variance_recent_avg="0.38"
Change_ratio_recent_avg="-0.75"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="96"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_negative_thumbnail_id_2="144"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="983"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0145.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
